These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11473046)

  • 21. Women at altitude: short-term exposure to hypoxia and/or alpha(1)-adrenergic blockade reduces insulin sensitivity.
    Braun B; Rock PB; Zamudio S; Wolfel GE; Mazzeo RS; Muza SR; Fulco CS; Moore LG; Butterfield GE
    J Appl Physiol (1985); 2001 Aug; 91(2):623-31. PubMed ID: 11457773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of alpha 1- and alpha 2-adrenoceptor stimulation and blockade on plasma insulin levels in the mouse.
    Skoglund G; Lundquist I; Ahrén B
    Pancreas; 1986; 1(5):415-20. PubMed ID: 2882501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose-induced decrease in glucagon and pinephrine responses to exercise in man.
    Galbo H; Christensen NJ; Holst JJ
    J Appl Physiol Respir Environ Exerc Physiol; 1977 Apr; 42(4):525-30. PubMed ID: 863812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic and metabolic responses to exercise after alpha 1-, beta 1-, and nonselective beta-adrenoceptor blockade in man.
    McLeod AA; Brown JE; Kitchell BB; Sedor FA; Kuhn DC; Williams RS; Shand DG
    Am J Med; 1984 Feb; 76(2A):97-100. PubMed ID: 6702866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon and insulin responses to alpha-adrenergic subtype receptor blockade in sheep.
    Oda S; Ohneda A; Tsuda T; Sasaki Y
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1990; 96(2):405-9. PubMed ID: 1980450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of carotid bodies in control of the neuroendocrine response to exercise.
    Koyama Y; Coker RH; Denny JC; Lacy DB; Jabbour K; Williams PE; Wasserman DH
    Am J Physiol Endocrinol Metab; 2001 Oct; 281(4):E742-8. PubMed ID: 11551850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists.
    Abdel-Zaher AO; Ahmed IT; El-Koussi AD
    Pharmacol Res; 2001 Nov; 44(5):397-409. PubMed ID: 11712871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.
    Berk MA; Clutter WE; Skor D; Shah SD; Gingerich RP; Parvin CA; Cryer PE
    J Clin Invest; 1985 Jun; 75(6):1842-51. PubMed ID: 3891786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.
    Tuttle KR; Marker JC; Dalsky GP; Schwartz NS; Shah SD; Clutter WE; Holloszy JO; Cryer PE
    Am J Physiol; 1988 Jun; 254(6 Pt 1):E713-9. PubMed ID: 3287952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenergic blockade prevents endotoxin-induced increases in glucose metabolism.
    Hargrove DM; Bagby GJ; Lang CH; Spitzer JJ
    Am J Physiol; 1988 Nov; 255(5 Pt 1):E629-35. PubMed ID: 2903674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The integrated effect of adrenergic blockade on glucose, fatty acid, and glycerol kinetics: responses in the basal state and during hormonal control with somatostatin-hormonal infusion.
    Shaw JH; Wolfe RR
    J Surg Res; 1987 Mar; 42(3):257-72. PubMed ID: 2881026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic role of the exercise-induced increment in epinephrine in the dog.
    Moates JM; Lacy DB; Goldstein RE; Cherrington AD; Wasserman DH
    Am J Physiol; 1988 Oct; 255(4 Pt 1):E428-36. PubMed ID: 3052103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic and hormonal responses to adrenoceptor antagonists in 48-hour-starved exercising rats.
    Benthem L; van der Leest J; Steffens AB; Zijlstra WG
    Metabolism; 1995 Oct; 44(10):1332-9. PubMed ID: 7476294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for activation of both adrenergic and cholinergic nervous pathways by yohimbine, an alpha 2-adrenoceptor antagonist.
    Bagheri H; Chale JJ; Guyen LN; Tran MA; Berlan M; Montastruc JL
    Fundam Clin Pharmacol; 1995; 9(3):248-54. PubMed ID: 7557820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of muscarinic cholinergic and alpha2-adrenergic mechanisms in growth hormone secretion during exercise in humans.
    Harada T; Yamauchi T; Tsukanaka A; Matsumura Y; Kurono M; Honda A; Matsui N
    Eur J Appl Physiol; 2000 Nov; 83(4 -5):268-73. PubMed ID: 11138563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of antilipolytic alpha(2)-adrenergic receptors by epinephrine during exercise in human adipose tissue.
    Stich V; de Glisezinski I; Crampes F; Suljkovicova H; Galitzky J; Riviere D; Hejnova J; Lafontan M; Berlan M
    Am J Physiol; 1999 Oct; 277(4):R1076-83. PubMed ID: 10516247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The direct effects of catecholamines on hepatic glucose production occur via alpha(1)- and beta(2)-receptors in the dog.
    Chu CA; Sindelar DK; Igawa K; Sherck S; Neal DW; Emshwiller M; Cherrington AD
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E463-73. PubMed ID: 10913048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological analysis of neurogenic, sympathetic responses mediated through alpha-1-, alpha-2-adrenergic and purinergic receptors in the dog saphenous vein.
    Hiraoka Y; Taniguchi T; Oshita M; Muramatsu I
    Pharmacology; 2000 May; 60(4):188-94. PubMed ID: 10828743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenoceptor antagonists, but not guanethidine, reduce glucopenia-induced glucagon secretion from perfused rat pancreas.
    Ito K; Hirose H; Kido K; Koyama K; Maruyama H; Saruta T
    Diabetes Res Clin Pract; 1995 Dec; 30(3):173-80. PubMed ID: 8861456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.